Remko van Leeuwen

Remko van Leeuwen

CEO, SurvivX

Remko van Leeuwen has more than 25 years of research experience under his belt, both in the industry as well as in the academic arena.
He has a medical background, and been trained as a clinical epidemiologist and has extensive experienced in clinical infectious disease management. He has obtained a PhD in clinical HIV studies.
After completing his PhD, he decided on a career switch and he terminated his hospital based clinical activities. Over the last 2 decades, he has various positions in drug development and clinical trial conduct. He has designed and executed numerous clinical trials and pre-clinical development programs.
He has been team leader of large multi-national successful research projects. He carries in depth knowledge of product development, including regulatory requirements, medical affairs, biostatistics and data analysis. He has followed the NIABA Masterclass of Biobusiness 2009/2010. In 2011 he founded Madam Therapeutics.